Ch. 1. Radioactivity, radionuclides, and radiopharmaceuticals -- ch. 2. Instrumentation -- ch. 3. Quality control -- ch. 4. Cerebrovascular system -- ch. 5. Thyroid, parathyroid, and salivary glands -- ch. 6. Cardiovascular system -- ch. 7. Respiratory system -- ch. 8. Gastrointestinal tract -- ch. 9. Skeletal system -- ch. 10. Genitourinary system and adrenal glands -- ch. 11. Conventional neoplasm imaging and radioimmunotherapy -- ch. 12. Inflammation and infection imaging -- ch. 13. Positron emission tomography (PET) imaging -- ch. 14. Legal requirements and radiation safety -- Appendix A. Characteristics of radionuclides for imaging and therapy -- Appendix B-1. Radioactivity conversion table for international system (SI) units : becquerels to curies -- Appendix B-2. Radioactivity conversion table for international system (SI) units : curies to becquerels -- Appendix C-1. Technetium 99-m decay and generation tables -- Appendix C-2. Other radionuclide decay tables -- Appendix D. Injection techniques and pediatric dosage -- Appendix E-1. Sample techniques for nuclear imaging -- Appendix E-2. Abnormal radiopharmaceutical distribution due to medications and other extrinsic factors -- Appendix F. Nonradioactive pharmaceuticals in nuclear medicine -- Appendix G. Pregnancy and breastfeeding -- Appendix H-1. General considerations for patients receiving radionuclide therapy -- Appendix H-2. Special considerations and requirements for iodine-131 therapy -- Appendix I. Emergency procedures for spills of radioactive material